Engineered Human Therapies

News digest #262 – Why 2019 is the year of living medicines + Nestlé & Codexis, + $14m for Phylagen

Feb 20, 2019

View All

Sep 25, 2026

Physics-grounded AI is getting Galux hits on the hardest antibody targets

Bio Design

Biomanufacturing Scale Up

Chemicals Materials

Food Agriculture

Aaron Blotnick

Sep 23, 2026

Saku Biosciences and Sable Fermentation Offer US Customers One Agreement From Strain Engineering Through Scale Up

Food Agriculture

Mohamed Soufi

Sep 17, 2026

Leaps by Bayer Leads Series A in Robigo, Betting on Engineered Microbes for Crop Protection

Engineered Human Therapies

Environment

Food Agriculture

Biomanufacturing Scale Up

Bio Design

Ai Digital Biology

Aaron Blotnick

Sep 15, 2026

One Model, Every Microbiome

Capital Markets

Biopharma Solutions Tools Tech

Sep 15, 2026

Bitrobius Genetics and the University of Cambridge secure a £700k ARIA grant to develop mitochondrial gene delivery technologies

Biopharma Solutions Tools Tech

Sep 15, 2026

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

Sep 25, 2026

Physics-grounded AI is getting Galux hits on the hardest antibody targets

Bio Design

Biomanufacturing Scale Up

Chemicals Materials

Food Agriculture

Aaron Blotnick

Sep 23, 2026

Saku Biosciences and Sable Fermentation Offer US Customers One Agreement From Strain Engineering Through Scale Up

Food Agriculture

Mohamed Soufi

Sep 17, 2026

Leaps by Bayer Leads Series A in Robigo, Betting on Engineered Microbes for Crop Protection

Engineered Human Therapies

Environment

Food Agriculture

Biomanufacturing Scale Up

Bio Design

Ai Digital Biology

Aaron Blotnick

Sep 15, 2026

One Model, Every Microbiome

Newletter & More

SynBioBeta

2027

May 3-6,

2027

San Jose Convention Center ·

CA, USA

Event Details

Join List

News digest #262 – Why 2019 is the year of living medicines + Nestlé & Codexis, + $14m for Phylagen

Read More

Physics-grounded AI is getting Galux hits on the hardest antibody targets

Saku Biosciences and Sable Fermentation Offer US Customers One Agreement From Strain Engineering Through Scale Up

Leaps by Bayer Leads Series A in Robigo, Betting on Engineered Microbes for Crop Protection

One Model, Every Microbiome

Bitrobius Genetics and the University of Cambridge secure a £700k ARIA grant to develop mitochondrial gene delivery technologies

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

Physics-grounded AI is getting Galux hits on the hardest antibody targets

Saku Biosciences and Sable Fermentation Offer US Customers One Agreement From Strain Engineering Through Scale Up

Leaps by Bayer Leads Series A in Robigo, Betting on Engineered Microbes for Crop Protection

One Model, Every Microbiome

Newletter & More

Newsletter

Newsletter

Newsletter

SynBioBeta 2027

Categories

Company

Newsletter

SynBioBeta 2027

Categories

Company

Newsletter

SynBioBeta 2027

Categories

Company